I have always thought Eltoprazine would get it through a grant from MJFF and Now ESS looks poised to get one. Good news on the IND front for Eltoprazine hopefully triggers a MJFF arrangement. On another note, any news related to Parkinson's has been non existent. GC did state they receibed good convection delivery data but couldn't talk about it. There are a lot of things going on behind the scenes and this is just one example of likely conversations with partners/buyers.